Livzon Pharma 1513

Livzon Pharma 1513

Postby winston » Tue Mar 24, 2015 9:10 am

not vested

<Result Ann>LIVZON PHARMA (01513.HK) annual net profit up 5.8%

LIVZON PHARMA (01513.HK) announced that its revenue for the year ended December 2014 increased 20% from a year ago to RMB5.544 billion.

Net profit grew 5.8% to RMB516 million, with EPS of RMB1.74.

A dividend of RMB0.1 was declared.

Besides, the company made a bonus issue on the basis of 3 shares for every 10 shares held.

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118528
Joined: Wed May 07, 2008 9:28 am

Re: Livzon Pharma 1513

Postby winston » Fri Apr 10, 2015 10:58 am

not vested

<Research Report>LIVZON PHARMA (01513.HK) initiated Buy, target at $62 - Citi
Nov 12, 2014

Citi Group initiated a Buy rating for LIVZON PHARMA (01513.HK), with a target price of $62.

This implies that the projected P/E for 2015 will be 24 times, slightly lower than other leading companies in the industry (25 times).

Despite the earning pressure this year, the broker observed the business transformation of Livzon Pharmaceutical from API to specialty drugs.

With business transformation, it is likely to trigger earnings and bring a clearer position to the group, placing more value on product innovation and differentiation.


Source: AAStocks Financial News
Web Site: www.aastocks.com
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118528
Joined: Wed May 07, 2008 9:28 am

Re: Livzon Pharma 1513

Postby winston » Thu Jul 16, 2015 3:05 pm

not vested

<Post Resumption> LIVZON PHARMA Once Surges 22% on Proposed Spin-Off

LIVZON PHARMA (01513.HK)(000513.SZ) proposed the spin-off and separate listing of Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd (a wholly-owned subsidiary of the company) on the National Equities Exchange and Quotations Co. Ltd. (also known as the New Third Board).

In this respect, the HKEX reminded the company that the proposed spin-off and separate listing does not meet the requirements of the Listing Rules (The listed parent company should not spin off subsidiaries for separate listing within three years from the initial listing).

However, the company said it will actively strive to obtain a waiver for this requirement.

The company's H shares opened up 7.5% this morning after trading resumed, then further reclaimed the 10MA and 250MA ($38.32 and $39.1) and once shot up 22% to the peak of $39.65.

It last traded at $37.35, up 15%, but on a volume of only 0.77 million shares. Its A shares hit limit-up at RMB58.82.

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118528
Joined: Wed May 07, 2008 9:28 am

Re: Livzon Pharma 1513

Postby winston » Tue Nov 03, 2015 11:07 am

not vested

Oct 28, 2015

LIVZON PHARMA 3Q Net Profit Up 16.8%

LIVZON PHARMA (01513.HK) announced the results for the third quarter ended 30 September 2015.

Net profit attributable to shareholders gained 16.8% over the prior year to RMB155 million, with EPS of RMB0.39.

Turnover amounted to RMB1.771 billion, up 18.75% yearly.

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118528
Joined: Wed May 07, 2008 9:28 am

Re: Livzon Pharma 1513

Postby winston » Tue Nov 03, 2015 2:23 pm

not vested

<Post Resumption>LIVZON PHARMA AH Shares Tumble 10%, 15%

LIVZON PHARMA (01513.HK) (000513.SZ) terminated asset restructuring and shifted for the proposed issue of A shares for capital raising.

Following the trade resumption, LIVZON PHARMA-H hit the low at $33.85 after morning's close and last printed at $34.05, plunging 15%, on increasing turnover to $22.27 million.

Its A-share hit limit-down at RMB48.02, marking more than 10-month low, with turnover of RMB368 million.

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118528
Joined: Wed May 07, 2008 9:28 am

Re: Livzon Pharma 1513

Postby winston » Fri Apr 22, 2016 9:00 am

not vested

<Result Ann>LIVZON PHARMA (01513.HK) 1Q Net Profit Up 26% to RMB230M

LIVZON PHARMA (01513.HK) announced that for the first quarter, the operating income rose 12.4% yearly to RMB1.746 billion; net profit rose 26% to $230 million, representing EPS of 60 fen.

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118528
Joined: Wed May 07, 2008 9:28 am


Return to L to R

Who is online

Users browsing this forum: No registered users and 7 guests